Guardant Health shares planned for resale

Guardant Health, Inc. shareholder Chris Freeman plans to resell up to 63,605 common shares through Charles Schwab & Co., Inc., with an indicated aggregate market value of $10,786,111.00.

Rhea-AI Filing Summary

Guardant Health, Inc. shareholder Chris Freeman plans to resell up to 63,605 common shares through Charles Schwab & Co., Inc., with an indicated aggregate market value of $10,786,111.00. The sale is linked to an employee stock option exercise using a broker payment for a cashless exercise on 08/10/2026.

The disclosure also notes a prior sale on 05/22/2026 of 24,406 Guardant Health shares for aggregate proceeds of $2,896,361.00 over the preceding three months.

Key Figures

Shares planned for resale: 63,605 shares Aggregate market value of planned resale: $10,786,111.00 Shares sold in prior 3 months: 24,406 shares +1 more

4 metrics

Shares planned for resale 63,605 shares Common shares associated with employee stock option exercise and broker payment for cashless exercise dated 08/10/2026

Aggregate market value of planned resale $10,786,111.00 Value associated with 63,605 Guardant Health common shares to be resold

Shares sold in prior 3 months 24,406 shares Guardant Health common shares sold on 05/22/2026

Aggregate amount of prior sale $2,896,361.00 Aggregate amount for 24,406 Guardant Health shares sold on 05/22/2026

Key Terms

cashless exercise, employee stock option exercise, aggregate market value

3 terms

cashless exercise financial

"Broker Payment for Cashless Exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

employee stock option exercise financial

"Employee Stock Option Exercise | Guardant Health, Inc."

aggregate market value financial

"63605 | 10786111.00 | 134196170 | 08/10/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Guardant Health (GH) shares are planned for resale in this Form 144?

Chris Freeman plans to resell up to 63,605 Guardant Health common shares. The planned transaction is associated with an employee stock option exercise and uses a broker payment structure for a cashless exercise dated 08/10/2026.

What is the aggregate market value of Guardant Health (GH) shares covered?

The planned resale covers Guardant Health common shares with an aggregate market value of $10,786,111.00. These shares, totaling 63,605, are expected to be sold through Charles Schwab & Co., Inc. in connection with an employee stock option exercise.

How will the Guardant Health (GH) stock option exercise be executed?

The stock option exercise is structured as a cashless exercise with a broker payment. Charles Schwab & Co., Inc. is listed in the transaction, and the date associated with this exercise and related sale is 08/10/2026.

Were any Guardant Health (GH) shares sold by Chris Freeman in the prior three months?

Yes. The disclosure shows a prior sale on 05/22/2026 of 24,406 Guardant Health common shares. The aggregate amount for this earlier transaction is reported as $2,896,361.00 over the preceding three-month period.

Which broker is involved in the planned Guardant Health (GH) share sale?

The broker involved is Charles Schwab & Co., Inc., located in Westlake, Texas. The firm is listed in connection with the planned resale of 63,605 Guardant Health common shares tied to an employee stock option cashless exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 05:11 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001871615
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Freeman Chris
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	63605	10786111.00	134196170	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/10/2026	Employee Stock Option Exercise	Guardant Health, Inc.			63605	08/10/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Chris Freeman 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	05/22/2026	24406	2896361.00

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Chris Freeman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)